Cargando…
Saroglitazar for the treatment of hypertrig-lyceridemia in patients with type 2 diabetes: current evidence
Diabetes mellitus (DM) is one of the most dreaded metabolic disorders in the world today. It is the leading cause of morbidity and mortality, and plays a cardinal role in quality of life and health economics. DM is associated with a high prevalence of microvascular and macrovascular complications. D...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403747/ https://www.ncbi.nlm.nih.gov/pubmed/25926748 http://dx.doi.org/10.2147/DMSO.S49592 |